Explore the words cloud of the OcuTher project. It provides you a very rough idea of what is the project "OcuTher" about.
The following table provides information about the project.
|Coordinator Country||Finland [FI]|
|Total cost||3˙933˙728 €|
|EC max contribution||3˙933˙728 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2016-11-01 to 2020-10-31|
Take a look of project's partnership.
|1||ITA-SUOMEN YLIOPISTO||FI (KUOPIO)||coordinator||807˙436.00|
|2||UNIVERSITEIT UTRECHT||NL (UTRECHT)||participant||635˙356.00|
|3||THE QUEEN'S UNIVERSITY OF BELFAST||UK (BELFAST)||participant||546˙575.00|
|4||UNIVERSITA DEGLI STUDI DI PADOVA||IT (PADOVA)||participant||516˙122.00|
|5||EBERHARD KARLS UNIVERSITAET TUEBINGEN||DE (TUEBINGEN)||participant||373˙824.00|
|6||CERTARA UK LIMITED||UK (LONDON)||participant||273˙287.00|
|7||OZ BIOSCIENCES SAS||FR (MARSEILLE)||participant||262˙875.00|
|8||UNIVERSITE DE STRASBOURG||FR (STRASBOURG)||participant||262˙875.00|
|9||TECHNISCHE UNIVERSITEIT EINDHOVEN||NL (EINDHOVEN)||participant||255˙374.00|
|10||20MED THERAPEUTICS BV||NL (ENSCHEDE)||partner||0.00|
|11||BAYER AKTIENGESELLSCHAFT||DE (Leverkusen)||partner||0.00|
|12||Bio-Ker s.r.l||IT (Gessate)||partner||0.00|
|13||DELSITECH OY||FI (TURKU)||partner||0.00|
|14||INNOCORE TECHNOLOGIES BV||NL (Groningen)||partner||0.00|
|15||Retina International||CH (Zürich)||partner||0.00|
|16||SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH||PL (KATOWICE)||partner||0.00|
|17||UNIVERSIDAD COMPLUTENSE DE MADRID||ES (MADRID)||partner||0.00|
|18||Vasgen ltd||UK (London)||partner||0.00|
Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big pharma has entered recently. Ocular drug development is a unique field in terms of drug targets and end-points of activity, local drug administration routes, tissue barriers and pharmacokinetics, drug delivery and formulation challenges and local toxicity issues. These issues are slowing down the development of drugs for the unmet needs in ophthalmology. The main objective of the proposal is to educate experts of preclinical ocular R&D to facilitate the success of European pharmaceutical industry and research community. This objective will be reached by joining forces of the leading European academic and industrial researchers in ophthalmology, materials science and nanomedicine, drug delivery and targeting, and systems pharmacology. We shall educate 15 Early Stage Researchers in a network where they will receive tailored, multi-disciplinary and inter-sectoral education in preclinical ocular drug development. The thesis projects are directed to the drug treatment of retinal diseases, the major challenge in the field. The proposal combines new drug candidates from the experts of ophthalmology, innovative drug delivery technologies from pharmaceutical scientists and companies, and modern in vitro, in silico and in vivo methods from various partners. The thesis projects include secondments in academic and industrial partner laboratories and course programme that encompasses the relevant fields in ocular drug development. Therefore, this proposal presents unique combination of innovation and education in the field with obvious need for such education. The ESRs and other outcomes of this project will greatly benefit the future competitiveness of European science and industry in this field of expanding importance.
|Call for applications||Other||2019-07-09 09:56:59|
|First online version of network public website||Websites, patent fillings, videos etc.||2019-07-09 09:56:59|
Take a look to the deliverables list in detail: detailed list of OcuTher deliverables.
|year||authors and title||journal||last update|
MD Al-Amin, Federica Bellato, Francesca Mastrotto, Mariangela Garofalo, Alessio Malfanti, Stefano Salmaso, Paolo Caliceti
Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges
published pages: 1611, ISSN: 1422-0067, DOI: 10.3390/ijms21051611
|International Journal of Molecular Sciences 21/5||2020-04-04|
Jian Liu, Miao Tang, Kevin Harkin, Xuan Du, Chang Luo, Mei Chen, Heping Xu
Singleâ€cell RNA sequencing study of retinal immune regulators identified CD47 and CD59a expression in photoreceptorsâ€”Implications in subretinal immune regulation
published pages: , ISSN: 0360-4012, DOI: 10.1002/jnr.24618
|Journal of Neuroscience Research||2020-04-01|
Daye Sun, Miao Tang, Li Zhang, Brian G Falzon, Dilli Babu Padmanaban, Davide Mariotti, Paul Maguire, Heping Xu, Mei Chen, Dan Sun
Microplasma assisted synthesis of gold nanoparticle/graphene oxide nanocomposites and their potential application in SERS sensing
published pages: 455603, ISSN: 0957-4484, DOI: 10.1088/1361-6528/ab2a23
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OCUTHER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "OCUTHER" are provided by the European Opendata Portal: CORDIS opendata.